Terns Pharma Oral GLP-1 Drug Leads to Greater Than 5% Weight Loss in Small Study
Terns Pharmaceuticals' experimental GLP-1 obesity drug TERN-601 showed a 5.5% reduction in…
FDA Approval for Sickle Cell Disease Gene-Therapy
In December 2023, the FDA approved two novel treatments for Sickle Cell…
Kipu Health acquires Hatch Compliance to expand behavioral health offerings
Kipu Health, a company specializing in technology solutions for behavioral health, has…
Live from Austin, Examining Health Equity
Julie Rovner is the chief Washington correspondent and host of KFF Health…
Plasma biomarkers help determine sports-related concussion neuropathology
New research conducted on adolescent Canadian athletes participating in high-risk contact sports…
With TV drug ads, what you see is not necessarily what you get
Drug ads on TV, social media, and the internet are prevalent, with…
Four year medical degrees reduce diversity of medical students and care for disadvantaged groups
Evie A Hall, a senior house officer in general medicine at University…
Reducing risk of bone fracture in people with rare genetic disorder
A recent study conducted by researchers from McGill University and Shriners Hospitals…
Radnet’s DeepHealth and HOPPR forge partnership to advance AI in healthcare
DeepHealth, a subsidiary of RadNet, Inc., partners with HOPPR to develop AI…
Diet May Affect Gut Hormones Less Than Drugs, Surgery
Researchers found that short-term adoption of low-carbohydrate or low-fat diets does not…